CSX [CSX] vs Canadian National [CNI] Detailed Stock Comparison
CSX
NASDAQ
Loading...
Canadian National
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: CSX wins in 4 metrics, Canadian National wins in 16 metrics, with 0 ties. Canadian National appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | CSX | Canadian National | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 21.74 | 17.53 | Canadian National |
| Price-to-Book Ratio | 5.34 | 2.69 | Canadian National |
| Debt-to-Equity Ratio | 159.51 | 97.21 | Canadian National |
| PEG Ratio | 17.45 | 15.61 | Canadian National |
| EV/EBITDA | 12.87 | 8.91 | Canadian National |
| Profit Margin (TTM) | 21.92% | 26.62% | Canadian National |
| Operating Margin (TTM) | 36.09% | 41.29% | Canadian National |
| EBITDA Margin (TTM) | 36.09% | 41.29% | Canadian National |
| Return on Equity | 24.82% | 22.30% | CSX |
| Return on Assets (TTM) | 7.25% | 7.75% | Canadian National |
| Free Cash Flow (TTM) | $2.72B | $3.15B | Canadian National |
| Dividend Yield | 1.83% | 1.81% | CSX |
| 1-Year Return | 4.21% | -16.48% | CSX |
| Price-to-Sales Ratio (TTM) | 4.67 | 3.38 | Canadian National |
| Enterprise Value | $85.41B | $57.06B | CSX |
| EV/Revenue Ratio | 6.03 | 4.58 | Canadian National |
| Gross Profit Margin (TTM) | 35.90% | 42.77% | Canadian National |
| Revenue per Share (TTM) | $7 | $27 | Canadian National |
| Earnings per Share (Diluted) | $1.63 | $5.28 | Canadian National |
| Beta (Stock Volatility) | 1.25 | 0.86 | Canadian National |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
CSX vs Canadian National Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| CSX | 0.51% | 1.20% | 6.11% | 22.34% | 7.10% | 10.17% |
| Canadian National | 0.09% | -0.31% | -11.80% | -8.65% | -9.69% | -9.12% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| CSX | 4.21% | 3.14% | 43.15% | 258.97% | 532.68% | 1,328.63% |
| Canadian National | -16.48% | -27.79% | -9.67% | 49.69% | 205.51% | 446.46% |
Performance & Financial Health Analysis: CSX vs Canadian National
| Metric | CSX | CNI |
|---|---|---|
| Market Information | ||
| Market Cap | $66.05B | $57.87B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 18,518,020 | 1,581,990 |
| 90 Day Avg. Volume | 18,119,080 | 1,674,763 |
| Last Close | $35.43 | $92.57 |
| 52 Week Range | $26.22 - $37.10 | $91.65 - $121.12 |
| % from 52W High | -4.50% | -23.57% |
| All-Time High | $40.12 (Feb 19, 2024) | $137.19 (Mar 28, 2022) |
| % from All-Time High | -11.69% | -32.52% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.03% | -0.01% |
| Quarterly Earnings Growth | -0.14% | 0.05% |
| Financial Health | ||
| Profit Margin (TTM) | 0.22% | 0.27% |
| Operating Margin (TTM) | 0.36% | 0.41% |
| Return on Equity (TTM) | 0.25% | 0.22% |
| Debt to Equity (MRQ) | 159.51 | 97.21 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $6.64 | $34.44 |
| Cash per Share (MRQ) | $0.21 | $0.35 |
| Operating Cash Flow (TTM) | $4.96B | $4.85B |
| Levered Free Cash Flow (TTM) | $1.55B | $1.67B |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.83% | 1.81% |
| Last 12-Month Dividend | $0.63 | $1.84 |
Valuation & Enterprise Metrics Analysis: CSX vs Canadian National
| Metric | CSX | CNI |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 21.74 | 17.53 |
| Forward P/E | 17.45 | 15.61 |
| PEG Ratio | 17.45 | 15.61 |
| Price to Sales (TTM) | 4.67 | 3.38 |
| Price to Book (MRQ) | 5.34 | 2.69 |
| Market Capitalization | ||
| Market Capitalization | $66.05B | $57.87B |
| Enterprise Value | $85.41B | $57.06B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 6.03 | 4.58 |
| Enterprise to EBITDA | 12.87 | 8.91 |
| Risk & Other Metrics | ||
| Beta | 1.25 | 0.86 |
| Book Value per Share (MRQ) | $6.64 | $34.44 |
Financial Statements Comparison: CSX vs Canadian National
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CSX | CNI |
|---|---|---|
| Revenue/Sales | $3.42B | $4.40B |
| Cost of Goods Sold | $2.38B | $2.63B |
| Gross Profit | $1.04B | $1.78B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $1.04B | $1.61B |
| EBITDA | $1.49B | $2.25B |
| Pre-Tax Income | $858.00M | $1.53B |
| Income Tax | $212.00M | $366.00M |
| Net Income (Profit) | $646.00M | $1.16B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CSX | CNI |
|---|---|---|
| Cash & Equivalents | $1.14B | $232.00M |
| Total Current Assets | $3.02B | $2.68B |
| Total Current Liabilities | $3.42B | $4.31B |
| Long-Term Debt | $19.01B | $19.34B |
| Total Shareholders Equity | $12.18B | $21.62B |
| Retained Earnings | $9.66B | $18.88B |
| Property, Plant & Equipment | $53.16B | $48.90B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CSX | CNI |
|---|---|---|
| Operating Cash Flow | $1.17B | $1.27B |
| Capital Expenditures | $-750.00M | $-519.00M |
| Free Cash Flow | $-141.00M | $645.00M |
| Debt Repayment | $-1.00M | $-5.64B |
| Common Stock Repurchase | $-421.00M | $-162.00M |
Short Interest & Institutional Ownership Analysis
| Metric | CSX | CNI |
|---|---|---|
| Shares Short | 23.54M | 6.32M |
| Short Ratio | 1.69 | 4.52 |
| Short % of Float | 0.01% | N/A |
| Average Daily Volume (10 Day) | 18,518,020 | 1,581,990 |
| Average Daily Volume (90 Day) | 18,119,080 | 1,674,763 |
| Shares Outstanding | 1.90B | 627.93M |
| Float Shares | 1.86B | 606.89M |
| % Held by Insiders | 0.00% | 0.03% |
| % Held by Institutions | 0.80% | 0.75% |
Dividend Analysis & Yield Comparison: CSX vs Canadian National
| Metric | CSX | CNI |
|---|---|---|
| Last 12-Month Dividend | $0.63 | $1.84 |
| Last 12-Month Dividend Yield | 1.83% | 1.81% |
| 3-Year Avg Annual Dividend | $0.50 | $2.17 |
| 3-Year Avg Dividend Yield | 0.35% | 0.52% |
| 3-Year Total Dividends | $1.51 | $6.52 |
| Ex-Dividend Date | Aug 29, 2025 | Mar 10, 2025 |